Mydecine Innovations Group Stock Analysis

Mydecine Pink Sheet Analysis Notes

The company recorded a loss per share of 4.68. Mydecine Innovations last dividend was issued on the 1st of April 2019. The entity had 1:45 split on the 1st of April 2019. Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Mydecine Innovations operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11 people.The quote for Mydecine Innovations Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Mydecine Innovations Group contact David Bartch at 720 277 9879 or learn more at https://www.mydecine.com.

Mydecine Innovations Investment Alerts

Mydecine Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mydecine Innovations's market, we take the total number of its shares issued and multiply it by Mydecine Innovations's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 1st of October, Mydecine Innovations secures the Risk Adjusted Performance of 0.1436, downside deviation of 47.05, and Mean Deviation of 39.16. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mydecine Innovations, as well as the relationship between them. Please verify Mydecine Innovations standard deviation and the relationship between the treynor ratio and kurtosis to decide if Mydecine Innovations Group is priced some-what accurately, providing market reflects its recent price of 0.006 per share. As Mydecine Innovations appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.

Mydecine Innovations Price Movement Analysis

Mydecine Innovations Outstanding Bonds

Mydecine Innovations Predictive Daily Indicators

Mydecine Innovations Forecast Models

Mydecine Innovations' time-series forecasting models are one of many Mydecine Innovations' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mydecine Innovations' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Mydecine Innovations prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mydecine shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Mydecine Innovations. By using and applying Mydecine Pink Sheet analysis, traders can create a robust methodology for identifying Mydecine entry and exit points for their positions.

When running Mydecine Innovations' price analysis, check to measure Mydecine Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mydecine Innovations is operating at the current time. Most of Mydecine Innovations' value examination focuses on studying past and present price action to predict the probability of Mydecine Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mydecine Innovations' price. Additionally, you may evaluate how the addition of Mydecine Innovations to your portfolios can decrease your overall portfolio volatility.